Cargando…
Identification of biomarkers for development of end-stage kidney disease in chronic kidney disease by metabolomic profiling
A critical issue in the management of chronic kidney disease (CKD) is to prevent patients from the progression to end-stage kidney disease (ESKD), however, there is only limited number of biomarkers for the discrimination of the high-risk CKD patients. We aimed to identify the metabolites which poss...
Autores principales: | Kimura, Tomonori, Yasuda, Keiko, Yamamoto, Ryohei, Soga, Tomoyoshi, Rakugi, Hiromi, Hayashi, Terumasa, Isaka, Yoshitaka |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4870629/ https://www.ncbi.nlm.nih.gov/pubmed/27188985 http://dx.doi.org/10.1038/srep26138 |
Ejemplares similares
-
Chiral amino acid metabolomics for novel biomarker screening in the prognosis of chronic kidney disease
por: Kimura, Tomonori, et al.
Publicado: (2016) -
Hypomagnesemia in Type 2 Diabetic Nephropathy: A novel predictor of end-stage renal disease
por: Sakaguchi, Yusuke, et al.
Publicado: (2012) -
d-Amino acids and kidney diseases
por: Kimura, Tomonori, et al.
Publicado: (2020) -
Intra-body dynamics of d-serine reflects the origin of kidney diseases
por: Okushima, Hiroki, et al.
Publicado: (2021) -
d-Serine as a sensor and effector of the kidney
por: Kimura, Tomonori, et al.
Publicado: (2023)